Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 12, 2021

SELL
$86.23 - $125.19 $4,311 - $6,259
-50 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$79.17 - $111.47 $19,792 - $27,867
-250 Reduced 83.33%
50 $4,000
Q3 2020

Oct 28, 2020

BUY
$81.91 - $134.94 $7,781 - $12,819
95 Added 46.34%
300 $31,000
Q2 2020

Jul 20, 2020

BUY
$54.33 - $89.52 $434 - $716
8 Added 4.06%
205 $16,000
Q4 2019

Jan 24, 2020

SELL
$51.21 - $59.06 $307 - $354
-6 Reduced 2.96%
197 $11,000
Q3 2019

Oct 15, 2019

BUY
$40.6 - $57.2 $162 - $228
4 Added 2.01%
203 $11,000
Q2 2019

Jul 10, 2019

BUY
$39.92 - $53.86 $6,307 - $8,509
158 Added 385.37%
199 $10,000
Q3 2018

Nov 01, 2018

BUY
$52.05 - $66.51 $2,134 - $2,726
41 New
41 $3,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $289M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.